iwCLL 2019: Dr. Nicole Lamanna on Biomarker Testing for Chronic Lymphocytic Leukemia (CLL)
As the science of chronic lymphocytic leukemia has advanced, we have learned much more detailed information about its biology and the specific chromosomes, genes, and proteins that contribute to the disease. Checking for specific abnormalities in chromosomes and genetic variants can help doctors evaluate a patient’s prognosis and predict what treatments might work best.